Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle

Quick facts

Phase 1 pipeline

• Cell-based therapy
• CELLISTEM-OA

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle portfolio CI brief
• Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle pipeline updates RSS

Related

• Sector hub: All tracked pharma companies